Review of drug recalls and quality of pharmaceutical products in Nepal.

Astha NeupaneMaheshwor BastakotiSabita TamangBasant Giri

Published in: BMJ open (2022)

Our analysis showed that number of recalls of substandard and falsified drugs are increasing in Nepal. Since the recall data in this paper did not include number of samples tested and location of samples collected, more studies to understand the prevalence of substandard and falsified drugs in Nepal is recommended.

Keyphrases

tertiary care
risk factors
drug induced
electronic health record
big data
emergency department